Palettes of vaccines and immunostimulatory monoclonal antibodies for combination
Keywords: 
Antibodies, Monoclonal/therapeutic use
Cancer Vaccines/therapeutic use
Neoplasms/therapy
Issue Date: 
2009
Publisher: 
American Association for Cancer Research
ISSN: 
1557-3265
Citation: 
Melero I, Martinez-Forero I, Dubrot J, Suarez N, Palazon A, Chen L. Palettes of vaccines and immunostimulatory monoclonal antibodies for combination. Clin Cancer Res 2009 Mar 1;15(5):1507-1509.
Abstract
Various monoclonal antibodies (mAb) target immune system molecules to enhance immunity by costimulating T cells (i.e., CD137, OX40, CD40, GITR) or interfering in coinhibitory signals (i.e., CTLA-4, PD-1). These powerful agents can be guided by cancer vaccines to enhance immunity against tumor but not self tissues. Clinically powerful therapeutic synergies are at hand.

Files in This Item:
There are no files associated with this item.


Statistics and impact
0 citas en
0 citas en

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.